Analysis of the central vasomotor effects of (−)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent
Central vasomotor effects of (−)-N-(1-phenylethyl)guanidine, a potent adrenergic neuron blocking agent, were studied. The compound was localized in the central sites by intracerebroventricular injection, topical application on the vasomotor center, intra-arterial (vertebral) injection, and intrathecal injection. It potentiated the carotid occlusion response, response to anoxia, spinal compression vasomotor response, and the threshold and optimal vasomotor responses to direct electrical stimulation of the medullary vasomotor center without affecting the peripheral norepinephrine pressor response and the nictitating membrane response. The peak effect was obtained in 15–20 min, and recovery occurred in 80–90 min. The compound probably made catecholamines unavailable to the vasomotor neurons, making them more excitable.